During the Southern Hemispheres flu season, pandemic influenza A(H1N1) behaved like seasonal flu, with a quick rise in cases after the first reports in May and a peak in late June to early July, followed by a 6-7 week period of decline.
To the Editor: The 20082009 economic recession frames the reality of the economic shortfalls that many health science libraries face and directly affects the ability of some academic obstetrics and gynecology departments to fulfill their missions. Budgets of these libraries have not kept pace with the increasing costs of scholarly journals (which constitute the largest portion of their expenditures); consequently, additional budget cuts now may result in loss of access to journals considered to be core materials for our specialty. This loss of library resources, in our opinion, represents implicit rationing of medical services because physicians need access to information to be able to deliver optimal medical care. (Source: The Journal of Minimally Invasive Gynecology)
The Chinese State Food and Drug Administration has issued that countrys first license for a vaccine against the pandemic influenza A(H1N1) virus.
SILVER SPRING, Md. (EGMN) The Food and Drug Administrations Oncologic Drugs Advisory Committee met on Sept. 2 and voted 10-4 that based on a study of patients with refractory or relapsed peripheral T-cell lymphoma response rates to pralatrexate are reasonably likely to predict clinical benefit in patients with this difficult-to-treat disease.
Immediate intervention for acute coronary syndromes without ST-segment elevation doesnt appear to be a more beneficial strategy than the usual approach of deferring intervention until the next working day, according to a report in the Sept. 2 issue of JAMA.
A retrospective study involving 13,809 patients found no evidence that proton pump inhibitors interfere with the antiplatelet drugs clopidogrel and prasugrel in patients with acute cardiac syndrome. Existing guidelines, which endorse the content use of proton pump inhibitors with antiplatelet drugs in these patients, will therefore not need to be changed.
